In a prospective 5-year study of children with acute encephalitis, evidence of Mycoplasma pneumoniae infection was demonstrated in 50 (31%) of 159 children. In 11 (6.9%) of these patients, M. pneumoniae was determined to be the probable cause of encephalitis on the basis of its detection in cerebrospinal fluid (CSF) by polymerase chain reaction (PCR) or by positive results of serologic tests for M. pneumoniae and detection of the organism in the throat by PCR. CSF PCR positivity correlated with a shorter prodromal illness ( ) and lack of P p .015 respiratory symptoms ( ). Long-term neurologic sequelae occurred in 64% of probable cases. Thirty P p .06 children (18.9%) who were seropositive for M. pneumoniae but did not have the organism detected by culture or PCR had convincing evidence implicating other organisms as the cause of encephalitis, suggesting that current serologic assays for M. pneumoniae are not sufficiently specific to establish a diagnosis of M. pneumoniae encephalitis.
In a prospective 5-year study of children with acute encephalitis, evidence of Mycoplasma pneumoniae infection was demonstrated in 50 (31%) of 159 children. In 11 (6.9%) of these patients, M. pneumoniae was determined to be the probable cause of encephalitis on the basis of its detection in cerebrospinal fluid (CSF) by polymerase chain reaction (PCR) or by positive results of serologic tests for M. pneumoniae and detection of the organism in the throat by PCR. CSF PCR positivity correlated with a shorter prodromal illness ( ) and lack of P p .015 respiratory symptoms ( ). Long-term neurologic sequelae occurred in 64% of probable cases. Thirty P p .06 children (18.9%) who were seropositive for M. pneumoniae but did not have the organism detected by culture or PCR had convincing evidence implicating other organisms as the cause of encephalitis, suggesting that current serologic assays for M. pneumoniae are not sufficiently specific to establish a diagnosis of M. pneumoniae encephalitis.
Acute childhood encephalitis is a potentially devastating illness with an incidence of ∼10.5 cases per 100,000 child-years in developed countries [1] . Among children !1 year old, the incidence may be as high as 27.7 cases per 100,000 child-years [2] . In the prevaccine era, measles, mumps, polio, and rubella were commonly implicated as etiologic agents of acute encephalitis [3, 4] . However, in more recent prospective studies, nonpolio enteroviruses, respiratory viruses, herpesviruses, and Mycoplasma pneumoniae have accounted for the majority of etiologically confirmed cases [1, 5, 6] .
Most large series published to date have relied ex-clusively on serologic tests for the diagnosis of M. pneumoniae encephalitis [1, 3, 5, [7] [8] [9] [10] [11] [12] [13] . Unfortunately, the glycolipid antigen extract of M. pneumoniae that is used in such assays is not specific, and false-positive results are a significant concern [14] [15] [16] [17] [18] [19] . Glycolipids that cross-react serologically occur commonly in plants [16] and in human brain tissue [17] . Fourfold or greater rises in CF titer to M. pneumoniae have been demonstrated in ∼40% of adult patients with bacterial meningitis and in ∼10% of those with other bacteremic infections [18] . False-positive M. pneumoniae IgM antibody responses have been detected in patients with acute meningoencephalitis and acute pancreatitis [19] . Among patients who have acute encephalitis, the detection of M. pneumoniae in the CSF by means of culture or PCR provides strong evidence of causality. However, absence of the organism in the CSF does not rule out M. pneumoniae as a cause, because CNS disease may be immunologically mediated. In this respect, the detection of M. pneumoniae in the respiratory tract of a patient with acute encephalitis provides supportive evidence of causality.
Since January 1994, The Hospital for Sick Children, Toronto, has maintained a prospective encephalitis reg-each primer, and 10 mL of sample DNA overlaid with mineral oil. PCR involved a 2-step reaction that was performed on the Robocycler 96 (Stratagene). The cycles were as follows: 1 cycle of 10 min at 95ЊC (for activation of AmpliTaq Gold), 40 cycles of 1 min at 95ЊC (for denaturation) and 1 min at 72ЊC (for annealing and extension), and 1 cycle of 3 min at 72ЊC (for final extension). The 209-bp product was then detected by gel electrophoresis by means of ethidium bromide staining. An extraction control (PBS) was run with each test to detect contamination. In addition, a reagent control and sensitivity control of 1 color-changing unit (CCU) were run. Each specimen was also tested to detect inhibition of the PCR reaction (1 CCU of M. pneumoniae was added to a duplicate PCR reaction). The sensitivity of our PCR assay was determined to be 0.1 CCU by use of a stock of M. pneumoniae with known concentration (as determined by culture of serial dilutions to determine 1 CCU).
Virus cultures were performed with AGMK and RD cell lines, for CSF and stool specimens, and with AGMK, MDCK, and HEp-2 cell lines, for throat and nasopharyngeal specimens. CSF was analyzed by reverse-transcriptase PCR and PCR for enteroviruses and all known herpesviruses, respectively [23] . Nasopharyngeal specimens were examined for the presence of respiratory syncytial virus, parainfluenza viruses (1, 2, and 3), influenza A and B viruses, and adenovirus by means of direct immunofluorescence microscopy and virus isolation in cell culture. Stool specimens were examined by use of electron microscopy for the presence of viral particles, and the specimens were inoculated into cell culture as described elsewhere [6] .
Definitions. Encephalopathy was defined as a depressed or altered level of consciousness, including lethargy, extreme irritability, or a significant change in personality or behavior that persisted for у24 h. Encephalitis was defined by the presence of encephalopathy plus у2 of the following criteria: fever (temperature, у38.0ЊC), seizure(s), focal neurologic findings, pleocytosis (WBC count, 15 cells/mL), EEG findings compatible with encephalitis, or abnormal neuroimaging.
All children who fulfilled the study criteria for encephalitis and in whom evidence of M. pneumoniae infection was detected either by means of serologic testing or by culture or PCR of throat or CSF specimens were included. Depending on the strength of the evidence that implicated M. pneumoniae, cases were classified as "probable," "possible," or "indeterminate" with respect to M. pneumoniae being the etiologic agent. Probable M. pneumoniae encephalitis was defined by either of the following 2 criteria: detection of M. pneumoniae in CSF specimens by means of PCR, culture, or both, with or without confirmatory results of serologic tests for M. pneumoniae; or detection of M. pneumoniae in throat specimens by means of PCR, culture, or both, with confirmatory results of serologic tests for M. pneumoniae. Possible M. pneumoniae encephalitis was defined by either serologic evidence of M. pneumoniae Convincing evidence for the presence of other pathogens was determined by the presence of one of the following: (1) detection of the organism in the CSF by means of culture or PCR; (2) detection of the organism in samples from a site other than the CSF by means of culture, PCR, antigen detection techniques, or electron microscopy; (3) serologic evidence of acute infection that was equally or more convincing than the evidence for M. pneumoniae; (4) in cases of suspected varicella encephalitis, a clinical diagnosis of varicella made at the time of or just before the development of encephalitis; or (5) a clinical presentation consistent with tuberculous meningitis with an appropriate exposure history and favorable response to antituberculous therapy.
RESULTS
Evidence for M. pneumoniae infection was detected in 50 (31%) of 159 children who were hospitalized with acute encephalitis from January 1994 through December 1998. Eleven of these patients (22%) had sufficient evidence of M. pneumoniae encephalitis for their cases to be classified as probable; among the remaining 39 patients, 9 cases (18%) were categorized as possible, and 30 cases (60%) were classified as indeterminate. Patients with probable M. pneumoniae encephalitis included 6 boys and 5 girls, who had a mean age of 7 years (range, 1-13 years). Patients with possible M. pneumoniae encephalitis included 3 boys and 6 girls, who had a mean age of 9.5 years (range, 1-17 years).
Microbiological findings. M. pneumoniae was detected by PCR in CSF samples from 6 children and in throat specimens obtained from an additional 5 children who were classified as having probable M. pneumoniae encephalitis (table 1) . No patient had M. pneumoniae detected at both sites. Three of the 6 children in whom M. pneumoniae was detected in CSF by means of PCR lacked detectable antibody to this organism in both acute-phase and convalescent-phase serum samples. All 3 
Bartonella henselae 5
Mycobacterium tuberculosis 2
NOTE.
The criteria for classification of cases of M. pneumoniae encephalitis as indeterminate are described in the Patients and Methods section.
a More than 1 agent was implicated in 10 patients.
of these children were !2 years old, and only 1 of them had a documented respiratory prodrome. Seven of 11 patients who had probable M. pneumoniae encephalitis had evidence of coinfection with at least 1 other organism (table 1) . In 2 patients, coinfection of the CNS by M. pneumoniae and HSV-2 was demonstrated by the detection of both organisms in the CSF by PCR. Amplicons produced by HSV-specific primers formed products characteristic for HSV-2 when digested with restriction endonucleases [23] . When digested with the restriction endonuclease AluI, the 209-bp amplicon produced by the M. pneumoniae-specific primers yielded 2 base-pair fragments of 134 and 75 bp, which is characteristic of M. pneumoniae. Cross-reactivity between the 2 organisms was excluded by demonstrating that the M. pneumoniae DNA was not amplified by the HSV-2 primers and that the HSV-2 DNA was not amplified by the M. pneumoniae primers.
The microbiological evidence for the possible cases of M. pneumoniae encephalitis is summarized in table 2. Viral respiratory coinfections were documented in 2 children. For 1 child, influenza A virus antigen was detected by immunofluorescence in a nasopharyngeal specimen, and a 14-fold rise in titer to the influenza A virus was demonstrated between acutephase and convalescent-phase serum samples. The other child had parainfluenza virus 2 isolated in culture of a specimen from the nasopharynx. Results of serologic tests for B. henselae in patient 16 were considered equivocal because of the lack of change in titer between acute-phase and convalescent-phase serum samples.
In all 30 of the children who were classified as having indeterminate M. pneumoniae encephalitis, the evidence that implicated other agents was equally or more compelling than that for M. pneumoniae. The possible etiologic agents are summarized in table 3. Nineteen children had particularly strong evidence that implicated agents other than M. pneumoniae as the cause of encephalitis. Enteroviruses were the likely etiologic agent in 6 children. In 1 child, enterovirus was isolated in culture of the CSF, and in another child it was detected by means of reverse-transcriptase PCR of the CSF. The remaining 4 children had a 4-fold increase or decrease in the CF titer to enterovirus. In 1 patient, HSV was detected in the CSF by PCR, and a 4-fold rise in the CF antibody titer was demonstrated between acute-phase and convalescent-phase serum samples. For 3 children, detection of adenovirus in the nasopharynx or stool was accompanied by positive results of serologic testing for adenovirus. Two patients exhibited a 4-fold rise in CF antibody titer to influenza A virus. VZV was the likely cause of encephalitis in 2 children who had active clinical varicella, 1 of whom also had VZV detected in the CSF by PCR. EBV was implicated in 1 patient in whom heterophile antibody as well as IgM and IgG to the EBV viral capsid antigen were detected in acute-phase serum samples. Two children had a у4-fold rise in antibody titer to B. henselae. Tuberculous meningitis was the likely diagnosis for 2 children. Although neither case was confirmed microbiologically, the patients' clinical presentation, CSF findings (lymphocytic pleocytosis and elevated levels of CSF protein), and response to antituberculous therapy strongly implicated Mycobacterium tuberculosis as the cause of the encephalitic presentation. The remaining 11 patients had serologic evidence of infection with other agents, including human herpesvirus 6 ( ), EBV ( ), influenza A virus n p 2 n p 2 ( ), enterovirus ( ), adenovirus ( ), and B. hen-
Clinical manifestations. Prodromal respiratory manifestations occurred in 7 of 11 patients with probable M. pneumoniae encephalitis and 6 of 9 patients with possible M. pneumoniae encephalitis (table 4). The duration of respiratory manifestations before admission varied from several days to as long as 4 weeks. Chest radiographs were performed for 6 patients with probable M. pneumoniae encephalitis and 3 patients with possible M. pneumoniae encephalitis; focal infiltrates and peribronchial thickening were detected in 4 and 2 patients, respectively. In patients without preceding respiratory symptoms, prodromal symptoms included fever, headache, vomiting, and diarrhea. One patient with probable M. pneumoniae encephalitis had no documented prodromal illness, and another had a mild febrile illness 2 weeks before the development of encephalitis, subsequent to receiving a routine measles-mumpsrubella vaccine.
The duration of prodromal illness was significantly shorter among children with positive M. pneumoniae CSF PCR than in children who had negative M. pneumoniae CSF PCR (P p by 2-tailed Fisher's exact test). In 5 of 6 children who had .015 M. pneumoniae detected in the CSF but not in the throat, the prodromal illness was р5 days in duration, whereas all 5 children in whom M. pneumoniae was detected in the throat but not in the CSF had prodromal symptoms у7 days in duration. Respiratory symptoms occurred in all children in whom M. pneumoniae was detected in the throat but in only 2 of 6 children in whom M. pneumoniae was detected in the CSF (P p by 2-tailed Fisher's exact test). .06
Neurologic manifestations in patients with probable or possible M. pneumoniae encephalitis included seizures, focal motor deficits, ataxia, and increased intracranial pressure (table 4) . Of the 13 patients with seizures, 8 had generalized tonic-clonic seizures and 5 had focal motor seizures. Focal neurologic deficits, independent of seizures, included hemiparesis, dysarthria, and aphasia. Encephalopathic manifestations included a decreased level of consciousness, disorientation, confusion, visual hallucinations, and extreme irritability. Acute demyelinating encephalomyelitis (ADEM) was diagnosed in 2 patients with probable M. pneumoniae encephalitis, 1 of whom also had optic neuritis. For both patients, PCR detected M. pneumoniae in specimens from the throat but not the CSF.
Specific therapy directed against M. pneumoniae was administered to 4 children in whom M. pneumoniae encephalitis was suspected (2 probable cases and 2 possible cases); 3 received macrolides, and 1 received doxycycline. Ten children were treated with acyclovir for presumed HSV encephalitis. Corticosteroids were administered to 1 patient with ADEM.
CSF findings. CSF specimens were available for all of the patients with probable or possible M. pneumoniae encephalitis ( 35 ϫ 10 7 ϫ 10 110 ϫ 10 with possible M. pneumoniae encephalitis. A predominance of lymphocytes (87%-100%) was documented in 9 of the 10 patients for whom a differential cell count was available. Among patients with probable or possible M. pneumoniae encephalitis, the mean CSF protein level was 42 mg/dL (range, 10-119 mg/ dL) and 37 mg/dL (range, 13-65 mg/dL), respectively. The CSF glucose level was 2.8-6.0 mM.
EEG and neuroimaging findings. EEG and neuroimaging (cranial CT, MRI, or both) were performed for all 20 patients with probable and possible M. pneumoniae encephalitis; EEG and neuroimaging abnormalities were demonstrated in 85% and 35% of these patients, respectively (table 4). Neuroimaging abnormalities included focal hemispheric lesions suggestive of an ischemic injury in 2 patients, focal temporal enhancing and edematous lesions in 1 patient in each category, and mild unilateral ventricular dilatation in 1 patient. Findings suggestive of ADEM included diffuse demyelination in 1 patient and edema of the basal ganglia, cerebral peduncles, and deep white matter in another. Results of single-photon emission CT scanning were normal in both patients with ADEM. Auditory and somatic evoked potentials were also normal in these 2 patients, but visual evoked responses were abnormal in the patient with concomitant optic neuritis.
Neurologic outcome. There were no deaths among patients in any of the 3 categories of M. pneumoniae encephalitis. The mean duration of follow-up for the 8 children with probable M. pneumoniae encephalitis in whom neurologic deficits were present at the time of discharge from the hospital was 1.8 years (range, 0-4 years). At least 6 months of follow-up data were available for 7 of 8 children with probable and 4 of 5 children with possible M. pneumoniae encephalitis who had neurologic deficits at the time of discharge. A seizure disorder that required prolonged anticonvulsant therapy developed in 4 patients with probable M. pneumoniae encephalitis and 1 patient with possible M. pneumoniae encephalitis. Mild cognitive impairments, including difficulty with concentration, memory, reading, and word finding, occurred in 4 of the 5 children who had seizure disorders. Other persistent neurologic deficits that occurred in patients with probable M. pneumoniae encephalitis included hemiparesis ( ), expressive dysphasia ( ), dysarthria n p 1 n p 1 ( ), and truncal ataxia ( ). The 2 children with n p 1 n p 1 ADEM, 1 of whom was treated with corticosteroids, made full recoveries over the course of several months. Three of the 4 children who were treated with macrolides or doxycycline experienced neurologic sequelae. Among children with possible M. pneumoniae encephalitis, 1 patient experienced severe developmental delay and concomitant hemiplegia. Other abnormal findings in this group of children included a speech disorder (word-finding difficulty) in 2 patients and asymptomatic ventriculomegaly and mild EEG abnormalities in 1.
DISCUSSION
M. pneumoniae was strongly implicated as the probable etiologic agent in 6.9% of 159 children with acute encephalitis. This figure is consistent with data from previous studies suggesting that 1%-10% of cases of acute childhood encephalitis are caused by this organism [1, [7] [8] [9] [10] [11] . The criteria for diagnosis of probable M. pneumoniae encephalitis included the detection of M. pneumoniae by culture or PCR of specimens from the throat, the CSF, or both to eliminate the potential impact of false-positive serologic test results. The detection of M. pneumoniae by PCR in these children provides conclusive evidence that all of them were infected, in the respiratory tract or CNS, at the time of or just before the development of encephalitis. By using more stringent diagnostic criteria than those of previous studies, we have strengthened the evidence implicating M. pneumoniae as a cause of acute childhood encephalitis.
M. pneumoniae is typically considered to be a potential cause of disease in children у5 years old who have respiratory symptoms. However, in our cohort, respiratory manifestations were absent in 4 (36%) of 11 patients with probable M. pneumoniae encephalitis and 3 (33%) of 9 patients with possible M. pneumoniae encephalitis. Among patients with probable M. pneumoniae encephalitis, respiratory symptoms occurred in all 5 children in whom M. pneumoniae was detected by PCR in the throat but not in the CSF, but in only 2 of 6 children in whom M. pneumoniae was detected in the CSF but not in the throat. The absence of respiratory manifestations has also been documented in several previous case reports of patients with encephalitis for whom PCR or culture detected M. pneumoniae in the CSF [24] [25] [26] [27] . In a recently reported study of patients with serologically confirmed systemic infections caused by M. pneumoniae, M. pneumoniae was detected in serum by PCR in only 1 of 25 patients with pneumonia but in 10 of 17 patients without pneumonia ( ) [28] . With respect to age, 4 of P ! .001 11 children in our cohort who had probable M. pneumoniae encephalitis and 2 of 9 children who had possible M. pneumoniae encephalitis were !5 years old (tables 1 and 2) . Four of these 6 children were !2 years old. Therefore, M. pneumoniae infection should be considered in the differential diagnosis of children with acute encephalitis, regardless of whether they have signs or symptoms of respiratory illness and regardless of their age.
The detection of M. pneumoniae in the brain tissue and CSF of patients with encephalitis indicates that direct invasion of the brain parenchyma is responsible for some cases of acute encephalitis [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] . We are aware of 2 cases in which M. pneumoniae was detected in brain tissue; in one, the organism was isolated in culture [29] , and in the other, it was detected by nucleic acid hybridization [30] . M. pneumoniae has also been isolated from the CSF by culture in 7 patients [24, [32] [33] [34] [35] and detected by PCR in an additional 26 patients, including those in our cohort [25-27, 31, 36-38] .
M. pneumoniae has been implicated as a cause of immunemediated neurologic syndromes, including ADEM, transversemyelitis, and Guillain-Barré syndrome [12, 36, [39] [40] [41] [42] [43] [44] [45] [46] . In our cohort, ADEM was diagnosed in 2 children in whom M. pneumoniae was detected in the throat but not in the CSF by PCR. The underlying pathogenesis of immune-mediated injury in patients with M. pneumoniae infection is incompletely understood, but it likely stems from the presence of antigenic similarities between M. pneumoniae and human tissues. M. pneumoniae infection has been associated with the production of a variety of anti-human antibodies, including IgM-class cold agglutinins, cold-reactive antilymphocyte antibodies, and antibodies to cardiolipin, smooth muscle, mitotic spindle apparatus, centriole, lung, liver, and brain [11, 17, [47] [48] [49] . CF antibodies to brain tissue antigens have been demonstrated in patients with and without CNS manifestations [17, 47] . The role of such antibodies in human disease has not been determined, although one report suggests that they are more common in subjects with CNS disease [50] . The deposition of immune complexes formed from such autoantibodies within small venules in the CNS has been implicated as a possible mechanism of immune-mediated neurologic injury [43, 51] .
In autoimmune-induced encephalitis, one would anticipate a more prolonged duration of symptoms before the onset of encephalitis and the presence of M. pneumoniae in the respiratory tract but not in the CSF. In our cohort, all 5 children in whom M. pneumoniae was detected by PCR in the throat but not in the CSF had prodromal symptoms of у7 days' duration. In contrast, 5 of the 6 children in whom M. pneumoniae was detected by PCR in the CSF but not in the throat had prodromal symptoms of р5 days' duration. These results are consistent with those of Narita et al. [28, 36] , who demonstrated a statistically significant association between the detection of M. pneumoniae in CSF samples and serum by PCR and fever of р7 days' duration before the onset of encephalitis. This lends support to the contention that autoimmune mechanisms are likely responsible for some cases of M. pneumoniae encephalitis, particularly those with prodromal symptoms of 15-7 days' duration.
Cerebrovascular thromboembolic phenomena have also been implicated as a potential cause of neurologic injury in patients infected with M. pneumoniae [52, 53] . Whether the cerebral infarcts that occurred in 2 of the children who we studied were caused by thromboembolic events, an autoimmune vasculitis, or some other pathologic process is uncertain. Neurotoxininduced neurologic disease occurs in mice infected with Mycoplasma neurolyticum and in turkeys infected with Mycoplasma gallisepticum, but no such toxin has been demonstrated in humans infected with M. pneumoniae [52] .
No immune response to M. pneumoniae could be demonstrated by either EIA or CF assays in the acute-phase or convalescent-phase serum samples of 3 of 6 children with probable M. pneumoniae encephalitis for whom the results of CSF PCR were positive (table 1). All 3 previously had been healthy, with no evidence to suggest an immune deficiency. The absence of a detectable serologic response could have been due to a lack of sensitivity of the assays or a failure to develop specific antibody. False-negative results of serologic tests for M. pneumoniae have been described elsewhere [29, [54] [55] [56] . In a study of 3546 patients with pneumonia, 10% of culture-proven M. pneumoniae infections were associated with acute-phase and convalescent-phase CF titers of р1:16, and only 53% had a у4-fold rise in the CF titer [54] . In studies that used the microparticle agglutination test and indirect immunofluorescence serologic assays, 15%-25% of children with PCR-proven respiratory infections caused by M. pneumoniae had negative results of serologic testing for the microorganism [55, 56] . Falsenegative results of CF for M. pneumoniae have also been documented in a fatal case of culture-proven infection of the CNS [29] and in a child who had M. pneumoniae detected in the CSF and the throat by PCR [25] . Thus, the absence of detectable antibodies to M. pneumoniae does not eliminate it as a possible cause of infection.
Strong evidence for coinfections, as determined by the direct detection of an organism by use of culture, PCR, or antigen detection techniques was demonstrated in 5 (45%) of the 11 patients who were classified as having probable M. pneumoniae encephalitis (table 1) . Respiratory viral infections can have cytotoxic effects on respiratory epithelium, and therefore it is conceivable that such infections could have facilitated bloodstream invasion by M. pneumoniae. Dual CNS infection with HSV-2 and M. pneumoniae, as was demonstrated in 2 of the children in our cohort, has not been previously reported. The presence of detectable antibody to HSV in one of these children at the onset of encephalitis and the lack of a 4-fold rise in HSV antibody titer in both children suggest that reactivation of latent HSV infection, rather than primary HSV infection, occurred in these 2 children. The pathogenetic role of other infectious agents detected by means of serologic tests alone in patients with probable M. pneumoniae encephalitis is questionable. M. pneumoniae has been shown to induce non-antigen-specific T cell-dependent antibody production in human B lymphocytes in vivo [57, 58] , and it is likely that the elevated levels of antibody to these other infectious agents are the result of nonspecific immune activation by M. pneumoniae.
Twenty-eight (93%) of 30 children who had indeterminate M. pneumoniae encephalitis had serologic evidence of infection with у1 other agent. Thirteen (43%) had evidence of infection with у2 agents, in addition to M. pneumoniae. A minority of these cases might represent true dual viral mycoplasmal infections or mycoplasma-induced nonspecific immune activation. However, in the majority of these cases, the evidence that implicated other agents as the cause of encephalitis was compelling, suggesting that false-positive results of serologic tests for M. pneumoniae were likely. Such false-positive results could be caused by cross-reactivity with human brain antigens [17, 19, 59] or by other inherent limitations in the specificity of serologic tests for M. pneumoniae [14] [15] . For all these reasons, we believe that in the absence of corroborating culture or PCR results, seropositivity is insufficient to establish a definitive diagnosis of M. pneumoniae encephalitis.
The clinical manifestations, CSF abnormalities, and EEG and neuroimaging findings associated with M. pneumoniae encephalitis are indistinguishable from those of viral encephalitis [6] . Long-term neurologic sequelae have been documented in 48%-54% of serologically confirmed cases of M. pneumoniae encephalitis [7, 12] . In our cohort, 7 (64%) of 11 children with probable M. pneumoniae encephalitis experienced neurologic sequelae.
Antibiotic therapy has been temporally associated with clinical improvement in some cases of M. pneumoniae encephalitis [12, 25, 31, 32, 34, 35, 37, 40, 42, 43] but not in others [11, 12, 26, 38, [42] [43] [44] [45] 59] . Complete neurologic recoveries without antibiotic therapy have also been described [24, 36, 41, 42] . Unfortunately, it is not possible to draw any conclusion regarding the efficacy of antibiotic therapy from the results of our study or from the data in the literature because of the small number of children treated, the uncertainty regarding the natural history of untreated infection, and the failure to use an antibiotic that penetrates the blood-brain barrier in many of the reported cases. Nevertheless, until more-definitive data become available, it is reasonable to consider antibiotic therapy for children who present with a short prodromal illness consistent with direct CNS infection. In theory, an antibiotic such as chloramphenicol, doxycycline, or a quinolone should be used, because of the antimycoplasmal activity of such antibiotics and their ability to traverse the blood-brain barrier.
The optimal management of this condition in children in whom immune-mediated neurologic injury is likely remains uncertain. At present, no data support or refute the potential benefit of antimicrobial therapy for such patients. Corticosteroids have been temporally associated with clinical improvement in a small number of patients with ADEM and serologically confirmed M. pneumoniae infection [12, 42-44, 60, 61] . The efficacy of corticosteroids in the treatment of M. pneumoniae-associated transverse myelitis is less well established [45] . Plasmapheresis appeared to be effective in 1 patient with M. pneumoniae transverse myelitis [62] and 1 patient with polyradiculitis [63] . No such benefit was seen with iv immunoglobulin [40] . Despite the lack of conclusive evidence, it is reasonable to consider the use of these immune-modulating therapies in addition to antibiotics in children with M. pneumoniae encephalitis who have severe disease.
Because of the difficulties associated with the serologic diagnosis and the prolonged incubation period required for culture, PCR is increasingly used for the diagnosis of M. pneumoniae infections [20-22, 28, 36, 37, 55, 56, 64-69] . In preliminary experiments that involved 114 clinical respiratory samples, 50 of which had culture results that were positive for M. pneumoniae, our PCR assay had a sensitivity, specificity, positive predictive value, and negative predictive value of 100%, 98.4%, 98%, and 100%, respectively, with culture serving as the gold standard (unpublished data). The high sensitivity and specificity of our assay are consistent with published data from other centers that used the same PCR primers [21] [22] .
Although the possibility of false-positive PCR results cannot be absolutely excluded, such an event is unlikely, given the design and execution of the assay. The detection of M. pneumoniae in the CSF of 6 children with encephalitis provides strong evidence that this organism was responsible for their illness, regardless of the results of serologic tests. The detection of M. pneumoniae in the throat but not in the CSF (in 5 probable cases) provided less-conclusive evidence of causality and therefore required the presence of supportive positive results of serologic tests for M. pneumoniae.
In conclusion, M. pneumoniae is responsible for at least 6.9% of cases of acute childhood encephalitis and is strongly associated with 12.5% of cases. Neurologic sequelae are common, occurring in 48%-64% of cases. Direct invasion of the CNS is the probable pathogenetic mechanism in children with a brief (р5 days' duration) prodromal illness. Immunologic phenomena, thromboembolic phenomena, or both may be the mechanisms responsible in children with more prolonged (у7 days' duration) prodromal illness. Coinfections with respiratory viruses and herpesviruses are common. Currently available EIA and CF tests for M. pneumoniae are not sufficiently specific to reliably diagnose acute childhood encephalitis caused by M. pneumoniae in the absence of corroborating evidence, such as positive culture or PCR.
